Modulation of β-catenin signaling by the inhibitors of MAP kinase, tyrosine kinase, and PI3-kinase pathways

International Journal of Medical Sciences

Volumn 10, Issue 13, 2013, Pages 1888-1898

  Zhang, Wenwen ^a,b,c   Zhang, Hongyu ^a,b   Wang, Ning ^b,d   Zhao, Chen ^b,d   Zhang, Hongmei ^a,b   Deng, Fang ^a,d   Wu, Ningning ^a,b   He, Yunfeng ^a,b   Chen, Xian ^a,b   Zhang, Junhui ^a,b   Wen, Sheng ^a,b   Liao, Zhan ^b   Zhang, Qian ^a,b   Zhang, Zhonglin ^b   Liu, Wei ^a,b   Yan, Zhengjian ^a,b   Luu, Hue H ^b   Haydon, Rex C ^b   Zhou, Lan ^a   He, Tong Chuan ^a,b  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^c Bingzhou Medical University Taishan Scholar Program   (China)

^d THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

catenin; G protein; MEK kinase; PI3 kinase; Protein kinase C; Tumorigenesis; Tyrosine phosphorylation; Wnt signaling

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 HYDROXYL 5 (2,5 DIHYDROXYBENZYLAMINO)BENZOIC ACID; 5,6 DICHLOROBENZIMIDAZOLE RIBOSIDE; BETA CATENIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II INHIBITOR; DIMETHYL SULFOXIDE; EPIDERMAL GROWTH FACTOR; GENISTEIN; LITHIUM CHLORIDE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE C ACTIVATOR; PROTEIN SERINE THREONINE KINASE INHIBITOR; PROTEIN TYROSINE KINASE INHIBITOR; SURAMIN; UNCLASSIFIED DRUG; WNT3A PROTEIN; WORTMANNIN;

ARTICLE; BETA CATENIN SIGNALING; BIOACCUMULATION; CANCER CELL; COLON CANCER; CONTROLLED STUDY; DRUG TARGETING; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

G PROTEIN; MEK KINASE; PI3 KINASE; PROTEIN KINASE C; TUMORIGENESIS; TYROSINE PHOSPHORYLATION; WNT SIGNALING.; Β-CATENIN;

BASE SEQUENCE; BETA CATENIN; BLOTTING, WESTERN; DNA PRIMERS; ENZYME ACTIVATION; FLUORESCENT ANTIBODY TECHNIQUE; GTP-BINDING PROTEINS; HEK293 CELLS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTEIN-TYROSINE KINASES; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TETRADECANOYLPHORBOL ACETATE;

EID: 84889604059     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.6019     Document Type: Article

References (70)

1. Nusse R, Fuerer C, Ching W, Harnish K, Logan C, Zeng A, et al. Wnt signaling and stem cell control. Cold Spring Harb Symp Quant Biol. 2008; 73: 59-66.
2. Miller JR. The Wnts. Genome Biol. 2002; 3.
3. Gordon MD, Nusse R. Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors. J Biol Chem. 2006; 281: 22429-33.
4. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell. 2006; 127: 469-80.
5. Luo J, Chen J, Deng ZL, Luo X, Song WX, Sharff KA, et al. Wnt signaling and human diseases: what are the therapeutic implications? Lab Invest. 2007; 87: 97-103.
6. Anastas JN, Moon RT. WNT signalling pathways as therapeutic targets in cancer. Nature reviews. 2013; 13: 11-26.
7. Clevers H, Nusse R. Wnt/beta-catenin signaling and disease. Cell. 2012; 149: 1192-205.
8. Kinzler KW, Nilbert MC, Su LK, Vogelstein B, Bryan TM, Levy DB, et al. Identification of FAP locus genes from chromosome 5q21. Science. 1991; 253: 661-5.
9. Groden J, Thliveris A, Samowitz W, Carlson M, Gelbert L, Albertsen H, et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell. 1991; 66: 589-600.
10. He TC, Chan TA, Vogelstein B, Kinzler KW. PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell. 1999; 99: 335-45.
11. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, et al. Identification of c-MYC as a target of the APC pathway [see comments]. Science. 1998; 281: 1509-12.
12. Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 1999; 398: 422-6.
13. Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R, et al. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci U S A. 1999; 96: 5522-7.
14. Wagner ER, Zhu G, Zhang BQ, Luo Q, Shi Q, Huang E, et al. The therapeutic potential of the Wnt signaling pathway in bone disorders. Curr Mol Pharmacol. 2011; 4: 14-25.
15. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell. 1996; 87: 159-70.
16. Rubinfeld B, Souza B, Albert I, Muller O, Chamberlain SH, Masiarz FR, et al. Association of the APC gene product with beta-catenin. Science. 1993; 262: 1731-4.
17. Su LK, Vogelstein B, Kinzler KW. Association of the APC tumor suppressor protein with catenins. Science. 1993; 262: 1734-7.
18. Morin PJ. beta-catenin signaling and cancer. Bioessays. 1999; 21: 1021-30.
19. Kim JH, Liu X, Wang J, Chen X, Zhang H, Kim SH, et al. Wnt signaling in bone formation and its therapeutic potential for bone diseases. Therapeutic advances in musculoskeletal disease. 2013; 5: 13-31.
20. Luu HH, Zhang R, Haydon RC, Rayburn E, Kang Q, Si W, et al. Wnt/beta-catenin signaling pathway as a novel cancer drug target. Curr Cancer Drug Targets. 2004; 4: 653-71.
21. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, et al. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC [see comments]. Science. 1997; 275: 1787-90.
22. Tang N, Song WX, Luo J, Luo X, Chen J, Sharff KA, et al. BMP9-induced osteogenic differentiation of mesenchymal progenitors requires functional canonical Wnt/beta-catenin signaling. J Cell Mol Med. 2009; 13: 2448-64.
23. Luo Q, Kang Q, Si W, Jiang W, Park JK, Peng Y, et al. Connective Tissue Growth Factor (CTGF) Is Regulated by Wnt and Bone Morphogenetic Proteins Signaling in Osteoblast Differentiation of Mesenchymal Stem Cells. J Biol Chem. 2004; 279: 55958-68.
24. Luo X, Chen J, Song WX, Tang N, Luo J, Deng ZL, et al. Osteogenic BMPs promote tumor growth of human osteosarcomas that harbor differentiation defects. Lab Invest. 2008; 88: 1264-77.
25. Huang E, Bi Y, Jiang W, Luo X, Yang K, Gao JL, et al. Conditionally Immortalized Mouse Embryonic Fibroblasts Retain Proliferative Activity without Compromising Multipotent Differentiation Potential. PloS one. 2012; 7: e32428.
26. Huang E, Zhu G, Jiang W, Yang K, Gao Y, Luo Q, et al. Growth hormone synergizes with BMP9 in osteogenic differentiation by activating the JAK/STAT/IGF1 pathway in murine multilineage cells. J Bone Miner Res. 2012;27:1566-75.
27. Luther GA, Lamplot J, Chen X, Rames R, Wagner ER, Liu X, et al. IGFBP5 Domains Exert Distinct Inhibitory Effects on the Tumorigenicity and Metastasis of Human Osteosarcoma. Cancer Lett. 2013;336:222-30.
28. Su Y, Wagner ER, Luo Q, Huang J, Chen L, He BC, et al. Insulin-like growth factor binding protein 5 suppresses tumor growth and metastasis of human osteosarcoma. Oncogene. 2011; 30: 3907-17.
29. Kang Q, Song WX, Luo Q, Tang N, Luo J, Luo X, et al. A comprehensive analysis of the dual roles of BMPs in regulating adipogenic and osteogenic differentiation of mesenchymal progenitor cells. Stem Cells Dev. 2009; 18: 545-59.
30. Chen L, Jiang W, Huang J, He BC, Zuo GW, Zhang W, et al. Insulin-like growth factor 2 (IGF-2) potentiates BMP-9-induced osteogenic differentiation and bone formation. J Bone Miner Res. 2010; 25: 2447-59.
31. Hu N, Jiang D, Huang E, Liu X, Li R, Liang X, et al. BMP9-regulated angiogenic signaling plays an important role in the osteogenic differentiation of mesenchymal progenitor cells. J Cell Sci. 2013;126:532-41.
32. Yang K, Chen J, Jiang W, Huang E, Cui J, Kim SH, et al. Conditional Immortalization Establishes a Repertoire of Mouse Melanocyte Progenitors with Distinct Melanogenic Differentiation Potential. J Invest Dermatol. 2012; 132: 2479-83.
33. Li M, Chen Y, Bi Y, Jiang W, Luo Q, He Y, et al. Establishment and characterization of the reversibly immortalized mouse fetal heart progenitors. International journal of medical sciences. 2013; 10: 1035-46.
34. Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW, et al. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/-colon carcinoma. Science. 1997; 275: 1784-7.
35. Zhou L, An N, Jiang W, Haydon R, Cheng H, Zhou Q, et al. Fluorescence-based functional assay for Wnt/beta-catenin signaling activity. Biotechniques. 2002; 33: 1126-8.
36. Sokol S, Christian JL, Moon RT, Melton DA. Injected Wnt RNA induces a complete body axis in Xenopus embryos. Cell. 1991; 67: 741-52.
37. He X, Saint-Jeannet JP, Woodgett JR, Varmus HE, Dawid IB. Glycogen synthase kinase-3 and dorsoventral patterning in Xenopus embryos [published erratum appears in Nature 1995 May 18;375(6528):253]. Nature. 1995; 374: 617-22.
38. Pierce SB, Kimelman D. Regulation of Spemann organizer formation by the intracellular kinase Xgsk-3. Development. 1995; 121: 755-65.
39. Chen RH, Ding WV, McCormick F. Wnt signaling to beta-catenin involves two interactive components. Glycogen synthase kinase-3beta inhibition and activation of protein kinase C. J Biol Chem. 2000; 275: 17894-9.
40. Peters JM, McKay RM, McKay JP, Graff JM. Casein kinase I transduces Wnt signals. Nature. 1999; 401: 345-50.
41. Sakanaka C, Leong P, Xu L, Harrison SD, Williams LT. Casein kinase iepsilon in the wnt pathway: regulation of beta-catenin function. Proc Natl Acad Sci U S A. 1999; 96: 12548-52.
42. Kuhl M, Sheldahl LC, Malbon CC, Moon RT. Ca(2+)/calmodulin-dependent protein kinase II is stimulated by Wnt and Frizzled homologs and promotes ventral cell fates in Xenopus. J Biol Chem. 2000; 275: 12701-11.
43. O'Dell TJ, Kandel ER, Grant SG. Long-term potentiation in the hippocampus is blocked by tyrosine kinase inhibitors. Nature. 1991; 353: 558-60.
44. Zhang Y, Neo SY, Wang X, Han J, Lin SC. Axin forms a complex with MEKK1 and activates c-Jun NH(2)-terminal kinase/stress-activated protein kinase through domains distinct from Wnt signaling. J Biol Chem. 1999; 274: 35247-54.
45. Boutros M, Paricio N, Strutt DI, Mlodzik M. Dishevelled activates JNK and discriminates between JNK pathways in planar polarity and wingless signaling. Cell. 1998; 94: 109-18.
46. Li L, Yuan H, Xie W, Mao J, Caruso AM, McMahon A, et al. Dishevelled proteins lead to two signaling pathways. Regulation of LEF-1 and c-Jun N-terminal kinase in mammalian cells. J Biol Chem. 1999; 274: 129-34.
47. Behrens J. Cross-regulation of the Wnt signalling pathway: a role of MAP kinases. J Cell Sci. 2000; 113: 911-9.
48. Fruman DA, Meyers RE, Cantley LC. Phosphoinositide kinases. Annu Rev Biochem. 1998; 67: 481-507.
49. Stein CS, Martins I, Davidson BL. Long-term reversal of hypercholesterolemia in low density lipoprotein receptor (LDLR)-deficient mice by adenovirus-mediated LDLR gene transfer combined with CD154 blockade. J Gene Med. 2000; 2: 41-51.
50. Stokoe D, Stephens LR, Copeland T, Gaffney PR, Reese CB, Painter GF, et al. Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B [see comments]. Science. 1997; 277: 567-70.
51. Delcommenne M, Tan C, Gray V, Rue L, Woodgett J, Dedhar S. Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. Proc Natl Acad Sci U S A. 1998; 95: 11211-6.
52. Espada J, Perez-Moreno M, Braga VM, Rodriguez-Viciana P, Cano A. H-Ras activation promotes cytoplasmic accumulation and phosphoinositide 3-OH kinase association of beta-catenin in epidermal keratinocytes. J Cell Biol. 1999; 146: 967-80.
53. Wodarz A, Nusse R. Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol. 1998; 14: 59-88.
54. Nusse R, Varmus HE. Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell. 1982; 31: 99-109.
55. Vleminckx K, Wong E, Guger K, Rubinfeld B, Polakis P, Gumbiner BM. Adenomatous polyposis coli tumor suppressor protein has signaling activity in Xenopus laevis embryos resulting in the induction of an ectopic dorsoanterior axis. J Cell Biol. 1997; 136: 411-20.
56. Rocheleau CE, Downs WD, Lin R, Wittmann C, Bei Y, Cha YH, et al. Wnt signaling and an APC-related gene specify endoderm in early C. elegans embryos [see comments]. Cell. 1997; 90: 707-16.
57. Ahmed Y, Hayashi S, Levine A, Wieschaus E. Regulation of armadillo by a Drosophila APC inhibits neuronal apoptosis during retinal development. Cell. 1998; 93: 1171-82.
58. Wang SS, Esplin ED, Li JL, Huang L, Gazdar A, Minna J, et al. Alterations of the PPP2R1B gene in human lung and colon cancer. Science. 1998; 282: 284-7.
59. Song DH, Sussman DJ, Seldin DC. Endogenous protein kinase CK2 participates in Wnt signaling in mammary epithelial cells. J Biol Chem. 2000; 275: 23790-7.
60. Kawasaki Y, Senda T, Ishidate T, Koyama R, Morishita T, Iwayama Y, et al. Asef, a link between the tumor suppressor APC and G-protein signaling. Science. 2000; 289: 1194-7.
61. Novak A, Hsu SC, Leung-Hagesteijn C, Radeva G, Papkoff J, Montesano R, et al. Cell adhesion and the integrin-linked kinase regulate the LEF-1 and beta-catenin signaling pathways. Proc Natl Acad Sci U S A. 1998; 95: 4374-9.
62. Papkoff J, Aikawa M. WNT-1 and HGF regulate GSK3 beta activity and beta-catenin signaling in mammary epithelial cells. Biochem Biophys Res Commun. 1998; 247: 851-8.
63. Hiscox S, Jiang WG. Association of the HGF/SF receptor, c-met, with the cell-surface adhesion molecule, E-cadherin, and catenins in human tumor cells. Biochem Biophys Res Commun. 1999; 261: 406-11.
64. Goruppi S, Chiaruttini C, Ruaro ME, Varnum B, Schneider C. Gas6 Induces Growth, beta-Catenin Stabilization, and T-Cell Factor Transcriptional Activation in Contact-Inhibited C57 Mammary Cells. Mol Cell Biol. 2001; 21: 902-15.
65. Playford MP, Bicknell D, Bodmer WF, Macaulay VM. Insulin-like growth factor 1 regulates the location, stability, and transcriptional activity of beta-catenin [In Process Citation]. Proc Natl Acad Sci U S A. 2000; 97: 12103-8.
66. Carmeliet P, Lampugnani MG, Moons L, Breviario F, Compernolle V, Bono F, et al. Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell. 1999; 98: 147-57.
67. Ishitani T, Ninomiya-Tsuji J, Nagai S, Nishita M, Meneghini M, Barker N, et al. The TAK1-NLK-MAPK-related pathway antagonizes signalling between betacatenin and transcription factor TCF. Nature. 1999; 399: 798-802.
68. Nishita M, Hashimoto MK, Ogata S, Laurent MN, Ueno N, Shibuya H, et al. Interaction between Wnt and TGF-beta signalling pathways during formation of Spemann's organizer. Nature. 2000; 403: 781-5.
69. Sheldahl LC, Park M, Malbon CC, Moon RT. Protein kinase C is differentially stimulated by Wnt and Frizzled homologs in a G-protein-dependent manner. Curr Biol. 1999; 9: 695-8.
70. Easwaran V, Pishvaian M, Salimuddin, Byers S. Cross-regulation of beta-catenin-LEF/TCF and retinoid signaling pathways. Curr Biol. 1999; 9: 1415-8.